Previous Article | Next Article ![]()
Infection and Immunity, August 2001, p. 4831-4838, Vol. 69, No. 8
Department of Microbiology and Immunology,
Medical College of Virginia at Virginia Commonwealth University,
Richmond, Virginia 23298-0678
Received 14 December 2000/Returned for modification 28 February
2001/Accepted 15 May 2001
Infection with Lyme disease spirochetes can be chronic. This
suggests that the spirochetes are capable of immune evasion. In a
previous study we demonstrated that the ospE gene family, which is one of three gene families whose members are flanked at their
5' end by the highly conserved upstream homology box (UHB) element,
undergoes mutation and rearrangement during infection. This results in
the generation of antigenically distinct variants that may contribute
to immune evasion. In this study we have assessed the genetic stability
of the UHB-flanked ospF gene family during infection in
mice. Using postinfection clonal populations of Borrelia burgdorferi B31MI, PCR amplicons were generated for three members of the ospF gene family after a 3-month infection time
frame. The amplicons were analyzed by single-nucleotide polymorphism pattern analysis and DNA sequencing. Members of the ospF
gene family were found to be stable during infection, as no mutations or rearrangements were detected. An analysis of the humoral immune response to these proteins during infection revealed that the immune
response to each is specific and that there is a delayed humoral immune
response to some OspF protein family members. These analyses suggest
that there is a temporal component to the expression of these genes
during infection. In addition to a possible contribution to immune
evasion, members of the OspF protein family may play specific roles at
different stages of infection.
Lyme disease is a chronic infection
caused by certain species of the Borrelia burgdorferi sensu
lato complex. In North America, B. burgdorferi is the
primary species associated with disease in humans. The ability of the
Lyme disease spirochetes to maintain chronic infection indicates that
they are capable of immune evasion. To date, two different genes or
gene families have been implicated in immune evasion, vls
and the ospE gene family (designated family 162 by the
Institute for Genomic Research [TIGR]) (20, 23). Recent
studies have demonstrated that the ospE gene family
undergoes mutation during infection, leading to the generation of OspE
variants that are antigenically distinct from the proteins expressed by the preinfection spirochete population (20). The mutations
that develop in the ospE genes are of two types, point
mutations that alter the amino acid sequence, and recombination events
between ospE alleles that generate polymorphic
OspE-related proteins. The vlsE gene also undergoes mutation
during infection (23). It is thought that vlsE
is involved in unidirectional recombination with a series of
vls pseudogenes, leading to the modification of the
vlsE sequence that is expressed. The resulting variants are
thought to encode antigenically distinct proteins.
The process of immune evasion in the Lyme disease spirochetes, as
mediated by antigenic variation, differs from the well-described system
of the relapsing fever spirochetes (3). During relapsing fever, a single Vmp is produced at high levels and becomes a dominant antigen of the outer membrane. In contrast, it is not yet clear if OspE
and VlsE are dominant proteins of the spirochetal cell surface during
infection in mammals. Hence, it is premature to conclude that they play
a similar dominant role in immune evasion as has been demonstrated for
the Vmps. The process of immune evasion during infection with the Lyme
disease spirochetes is likely to be multifactorial and may be mediated
by several different genes or gene families.
The ospE gene family is one of three gene families whose
members are flanked at their 5' end by a highly conserved,
promoter-carrying sequence element called the upstream homology box
(UHB) element (1, 2, 5, 11, 21). The focus of this
study is the ospF gene family (designated family 164 by TIGR), which in B. burgdorferi B31MI contains three
members, BBO39, BBR42, and BBM38 (TIGR designations). The members of
this family, their general properties, and alternative nomeclatures
that have been assigned are listed in Table
1. It should be noted that TIGR has
placed a fourth gene in this family, BBS41. However, evolutionary
analyses have suggested that this gene is a peripheral member of the
ospF family (11), and as a result this gene was
not analyzed as part of this report. All of the ospF gene
family members are carried by plasmids belonging to the cp32 plasmid
family (4, 19).
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.4831-4838.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Demonstration of the Genetic Stability and Temporal Expression of
Select Members of the Lyme Disease Spirochete OspF Protein Family
during Infection in Mice
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
OspF protein family of B. burgdorferi B31MI
From the variable sequence and molecular properties of the UHB-flanked genes, we hypothesized that mutational and recombination events occur frequently in these genes (11, 21), resulting in the generation of new UHB-flanked gene variants that encode proteins with altered antigenic characteristics. In an analysis of the ospE gene family, we demonstrated this hypothesis to be correct (20). Since all of the UHB-flanked genes encode potentially surface-exposed lipoproteins, it follows that mutational events in members of the UHB-flanked ospF and 163 gene families could also lead to the development of new antigenic variants that could contribute to immune evasion. In addition, differential expression of UHB-flanked genes could also alter the antigenic characteristics of the Lyme disease spirochetes. While discrepancies exist in the literature regarding the expression patterns of the UHB-flanked genes, it has been clearly demonstrated that the UHB-flanked genes encode immunogenic proteins that are expressed at some point during infection (1, 6, 17, 22).
In this report we focus our analyses on the ospF gene family and have sought to assess the genetic stability of these genes and their expression patterns during infection. The analyses presented here demonstrate that the frequency of mutation in these genes is low during infection in mice. Analyses of the humoral immune response to these proteins revealed that there is a temporal component to this response, suggesting that different members of the family are expressed at different times during infection. These studies shed further light on the hypothesized role of the OspF protein family during infection and specifically in immune evasion.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial isolates, cultivation, and experimental infection of mice. B. burgdorferi B31MI, kindly provided to us by MedImmune Inc. (Gaithersburg, Md.), was used for these analyses because the entire genome sequence has been determined for this isolate (7). This isolate was cultivated in BSK-H complete medium (Sigma) at 33°C. We previously confirmed the infectivity of this clone in C3H-HeJ mice (20). All clonal populations derived from B31MI used in this study were generated as part of an earlier analysis of the genetic stability of the ospE genes (20). To obtain postinfection clonal populations, subsurface plating of cultures obtained from ear punch biopsies was performed as previously described (20). The plates were incubated at 33°C under 3.2% CO2 in a humidified CO2 incubator. Approximately 2 to 3 weeks later, individual colonies were cored from the plates using a sterile Pasteur pipette. The colony-containing plugs of agarose were inoculated into 2 ml of complete BSK-H medium and cultivated at 33°C.
PCR analysis of ospF gene family members in clonal
populations of B. burgdorferi B31MI.
To PCR amplify
the ospF gene family members of B. burgdorferi
B31MI and its clonal derivative, isolated genomic DNA (~50 ng) was
used as the template with the primers listed in Table
2. DNA was isolated as previously
described (10). In some cases template DNA was obtained by
collecting well-isolated B. burgdorferi colonies (derived
from spirochete cultures recovered from ear punch biopsies),
transferring them into 2 ml of complete BSK-H medium, and cultivating
them to mid-log phase. Then 100-µl aliquots were removed, and cells
were pelleted, washed with phosphate-buffered saline (PBS), and
resuspended in 100 µl of H2O. The cell suspension was
boiled for 10 min and centrifuged to pellet debris, and 1 µl of the
supernatant was used as the template in PCR. PCR was performed with
Taq polymerase (Promega) for 30 cycles in an MJ Research
PTC100 thermal cycler with a hot bonnet. Reaction volumes were 30 µl,
and final primer set concentrations were 1 pmol of primer pair per
µl. Cycling conditions were as follows: 1 cycle of 5 min at 94°C,
followed by 30 cycles of 1 min at 94°C, 1 min at 50°C and 1.5 min
at 72°C. The resulting amplicons were analyzed by agarose gel
electrophoresis.
|
Rapid screening for ospF mutations. ospF-related genes were amplified from B. burgdorferi B31MI and postinfection clonal populations using a variety of primer sets as described above. As a control for these analyses, we also amplified and performed single-nucleotide polymorphism (SNP) analyses on the vlsE gene, which is known to undergo mutation during infection in mice. The purified ospF and vlsE amplicons obtained from these clonal populations then served as the template for SNP analyses as previously described (20). It is important to note that the vlsE and ospF SNP analyses were performed using the same set of clones. The SNP approach is essentially a limited sequencing approach in that only one of the four dideoxynucleotide incorporation reactions is performed. Comparison of the resulting ladders on a 6% polyacrylamide-8 M urea sequencing gel provides a rapid means for screening for mutations. To perform the SNP analyses, the Excel-Sequencing kit (Epicentre Technologies) and 5'-end, 32P-labeled primers were used.
Cloning and sequence analysis of PCR amplicons.
To determine
the complete sequence of representative ospF gene family
members from different postinfection clonal populations, the amplicons
were TA cloned into the pGEM-T-Easy vector as described by the
manufacturer (Promega). To identify Escherichia coli clones harboring ospF-carrying recombinant (r-) plasmids, the cells
were plated onto Luria-Bertani (LB) plates (amplicillin, 50 µg
ml
1), and individual colonies were picked with sterile
toothpicks and resuspended in 100 µl of distilled H2O.
The resuspended cells were boiled for 10 min, and 1 µl of the cell
lysate was used as the template in PCR with gene-specific PCR primer
sets. R-plasmids carrying the appropriate inserts were used as the
template for sequence analysis. Sequencing was accomplished using
end-labeled primers and the Excel-Sequencing kit as described by the
manufacturer (Epicentre Technologies). Sequencing reactions were run on
6% polyacrylamide-8 M urea gels, and autoradiography was performed. The determined sequences were translated using the Translate program, and both the nucleotide and amino acid sequences were aligned using the
Pileup program and manually adjusted. These programs are contained
within the Wisconsin-GCG sequence analysis package.
Immunoblot procedures and LIC and expression of OspF paralogs:
analysis of humoral immune response to OspF in experimentally infected
mice.
The humoral immune response to OspF variants was assessed by
immunoblotting. The test antigens for these analyses were generated by
PCR amplifying ospF gene family members from B. burgdorferi B31MI-derived clones with primers possessing tail
sequences that complement the single-stranded overhangs of the
ligase-independent cloning (LIC) pT7Blue-2 LIC vector (Novagen). After
PCR was performed, the single-stranded overhangs on the amplicon were
generated by treatment with T4 DNA polymerase in the presence of dATP
(other deoxynucleoside triphosphates are omitted) as described by the manufacturer (Novagen). To summarize, the 3'-to-5' exonuclease activity
of the T4 DNA polymerase will digest the amplicon until it reaches the
first A residue under the reaction conditions described above. The
first A residue in the primers above corresponds to the first base of
the start codon and the last base of the stop codon. When these bases
are encountered by the DNA polymerase, the 5'-3' polymerase activity
counteracts its exonuclease activity, resulting in an amplicon with
single-stranded overhangs that complement the vector. The treated
amplicon and pT7Blue2-LIC vector were then annealed and transformed
into E. coli NovaBlue Singles competent cells (Novagen),
using a standard transformation protocol, where covalent bond formation
occurs and the plasmid is propagated. To identify colonies harboring
the correct r-plasmid, colonies were selected, placed in 100 µl of
H2O (after generating a master plate with all analyzed
colonies), and boiled for 10 min, and 1 µl was used as the template
in PCR with the appropriate primer set. Selected recombinants carrying
the appropriate plasmid were inoculated into 3 ml of LB (ampicillin,
100 µg ml
1) and grown to an optical density at 600 nm
of 0.6, and then protein expression was induced with 0.4 mm IPTG
(isopropylthiogalactoside) for 3 h. The expressed protein
represents a fusion protein with a 62-amino-acid S-Tag fused to its N
terminus. The induced cells were pelleted and cell lysates were
analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) on a 15% gel.
or with E. coli that had been induced to express BBO39 as
follows. The E. coli cells were boiled in PBS for 15 min,
and then an aliquot of the cell lysate was incubated with the diluted
antiserum (in blocking buffer) overnight at 4°C. The sample was
centrifuged to pellet cellular debris and bound antibody, and the
supernatant was recovered. Another aliquot of E. coli was
added, and the samples were incubated for 1 h at room temperature.
The immunoblots were added to the preabsorbed sera, incubated at room
temperature for 1 h, and washed three times with wash buffer (1×
PBS, 0.2% Tween, 0.002% NaCl). For analysis of the IgG response,
ImmunoPure goat anti-mouse IgG (heavy and light chain)
peroxidase-conjugated secondary antibody was used at a dilution of
1:40,000. The secondary antibody was incubated with the blots for
1 h at room temperature and then washed three times with wash
buffer. For chemiluminescent detection, the Supersignal West Pico
stable peroxide solution and the Supersignal West Pico luminol/enhancer
solution were used. Both reagents were from Pierce. The immunoblots
were exposed to film.
| |
RESULTS |
|---|
|
|
|---|
PCR analyses of ospF gene family members in
postinfection clonal populations.
Several studies have
demonstrated that borrelial plasmids can be lost during cultivation
(14, 16) or during infection in mice (12).
Knowledge of the cp32 plasmid composition is essential in order to
accurately interpret the data obtained in the course of this study. To
determine if the plasmids that carry the ospF gene family
members were maintained by the clonal populations analyzed here after
12 weeks of infection in mice, PCR analyses were performed using
plasmid- or gene-specific primers (a comprehensive experimental flow
chart is shown in Fig. 1). Of relevance
to this report are plasmids cp32-4, cp32-6, and cp32-7, which carry the ospF gene family members BBR42, BBM38, and BBO39,
respectively (7). All 30 postinfection clones yielded
BBO39 and BBR42 amplicons, indicating that they carry cp32-4 and cp32-7
(Fig. 2). All but one of the clones was
found to carry cp32-6. Clone 9 was found to have lost cp32-6, as
evidenced by the absence of amplification of BBM38. The absence of
cp32-6 from this clone was confirmed through hybridization analysis in
a separate study (12). Analysis of the size of the
amplicons obtained for each gene from each clonal population revealed
all to be of the predicted size. This observation suggests that
large-scale rearrangements or mutational events did not occur within
these genes during cultivation. However, since small-scale
rearrangements, insertions, and/or deletions would not be detected by
the PCR approach applied above, SNP analyses were performed as
described below.
|
|
SNP pattern analysis of ospF gene family members in clonal populations after infection in mice. SNP analyses offer a rapid means for assessing whether mutational events have occurred in a gene of interest. By this approach, one simply compares sequencing ladders generated using one of the four nucleotides for a series of templates. In this case, the BB039, BBM38, and BBR42 ddATP ladders, obtained from the analysis of amplicons derived from a series of 30 postinfection clonal populations, were compared. This approach allows one to determine if changes have developed among clonal populations in ospF gene family members during infection in mice. The clones selected for analysis represent a subset of those that we characterized previously with regard to the genetic stability of the ospE genes during infection (20). These clones were found to either undergo recombination events or develop mutations in ospE during a 3-month infection time frame in C3H-HeJ mice. As an additional positive control for our ability to detect mutations by this approach, we also conducted SNP analyses of the vlsE gene, which is known to experience mutation during infection in C3H-HeJ mice (23). In contrast to the vlsE and ospE genes, mutations were not detected in the BBR42, BBM38, and BBO39 genes in these 30 different clonal populations (Fig. 2). From these analyses, it can be concluded that in B. burgdorferi B31MI, members of the ospF gene family are genetically stable during infection.
Analysis of humoral immune response to OspF protein family
members.
To allow an assessment of the specificity and development
of the humoral immune response to OspF protein family members, the BBO39, BBM38, and BBR42 genes were PCR amplified using primers generated for LIC cloning and expressed in E. coli. To
verify that the cloned genes were expressed in E. coli,
immunoblot analyses were performed using an S-protein directed against
the S-Tag segment of the r-fusion proteins (Fig.
3). R-proteins of the appropriate size
were detected for each of the constructs, confirming expression. The
relatively equivalent amounts of protein detected in the immunoblot analyses indicate that expression levels were comparable for each. This
observation is of importance for evaluating the data presented below.
|
Analysis of temporal pattern of humoral immune response to OspF
protein family members during infection of C3H-HeJ mice with B. burgdorferi B31MI.
To determine if there is a temporal
aspect to the humoral immune response to OspF-related proteins, serum
samples were collected at 2-week intervals up to 12 weeks from mice
that had been infected by needle inoculation with B. burgdorferi B31MI pc. Lysates of E. coli cells
that had been induced with IPTG to express each r-protein were used as
the test antigen in immunoblot analyses. The serum samples were first
preabsorbed with E. coli DH5
cells. Immunoblot analyses
using sera from two mice revealed a weak IgG response to BBO39 by week
4 of infection (data not shown) and a strong response by week 6 (Fig.
4). BBR42 was found to be only weakly
immunoreactive, while BBM38 was not reactive with these infection-derived sera even after 12 weeks of infection. The absence of
an early response to BBR42 and BBM38 in both mice suggests that, in
contrast to BBO39, these proteins are not expressed during early
infection. An alternative interpretation is that BBR42 and BBM38 are
expressed but that these proteins are only weakly immunogenic. However,
earlier studies have demonstrated that the OspE-, and OspF-related
proteins are immunogenic in mice (1, 6, 9, 13, 17, 22).
|
Analysis of specificity of antibody response to BBM38 and BBR42. The experiments above demonstrated that in some mice, an antibody response to BBM38 and BBR42 does not develop until late stages of infection. It is possible that the immunoreactivity of BBM38 and BBR42 with the late stage infection sera could be due to an expansion of the antibody response to BBO39, resulting in cross-immunoreactivity of anti-BBO39 antibodies with these proteins. To test for this possibility, immunoblots of the r-proteins were screened with the infection sera from mice infected with B31MI c53 that had been preabsorbed with lysates of E. coli that had been induced to express BBO39 (Fig. 4). Preabsorption eliminated immunoreactivity with rBBO39 but had no effect on the immunoreactivity of BBR42 and BBM38. These analyses demonstrate that the antibodies that develop late in infection to BBO39 and BBR42 are in fact specific for these proteins and are not cross-reactive antibodies. This observation provides further evidence for the late-stage-specific expression of BBM38 and BBR42 during infection.
Analysis of antibody response to OspF protein family members in mice infected with B. burgdorferi N40 and 297. To determine if other isolates express antigenically related proteins and exhibit a similar temporal pattern of expression, mice were infected with clones of B. burgdorferi N40 and 297 (N40c1 and 297c1, respectively). It is important to note that the genome sequence for these isolates has not been determined, and as a result the composition of the ospF gene family in these isolates has not been fully defined. This is an unavoidable caveat in analyses that deal with isolates other than B31MI. The first step in these analyses was to determine if these isolates carry genes related to BBO39, BBR42, and BBM38. Towards this goal, PCR analyses were performed. PCR amplification was observed with both N40 and 297 using the BBO39-(strong amplification) and BBR42 (moderate amplification)-specific primer sets (data not shown). For BBM38, strong amplification was observed with isolate 297, while no product was obtained from isolate N40. Hence, it appears either that N40 lacks BBM38 or that its sequence is divergent enough that amplification will not occur with the primer set used. In any event, these analyses indicate that the clones of isolates 297 and N40 used here carry sequences related to at least some of these genes.
To conduct the immunoblot analyses, serum samples were collected from the infected mice at 2 week intervals up to 12 weeks postinfection, and immunoblots identical to those described above were screened with the infection-derived sera (Fig. 5). The sera from these mice collected 8 weeks into infection reacted strongly with BBO39, indicating that the time frame for induction of an anti-BBO39 IgG response is similar in mice infected with these heterologous strains (note that sera from week 6 of infection were not available for analysis). It can be concluded that N40 and 297 express an OspF-related protein that has epitopes in common with BBO39 of B. burgdorferi B31MI. Regarding BBM38 and BBR42, consistent with the trends observed in the mice infected with B. burgdorferi B31MI pc and c53, an IgG response to these proteins was not observed through 12 weeks of infection. The absence of an antibody response to BBM38 and BBR42 in the sera of mice infected with N40 or 297 could be due to several possibilities. There could be significant sequence divergence in these proteins or, as observed in the B31MI-infected mice, the expression of these proteins could be repressed during infection.
|
| |
DISCUSSION |
|---|
|
|
|---|
Evolutionary analyses have demonstrated that B. burgdorferi B31MI carries three well-defined UHB-flanked gene families, ospE, ospF, and family 163 (2, 11). The focus of this report is the ospF gene family, which in B. burgdorferi B31MI comprises three members: BBR42, BBO39, and BBM38 (7). Comparative analyses of ospF-related genes from different isolates have demonstrated that these genes are highly variable, suggesting recent modification by mutational and recombination events (11, 18, 21). Based on this observation and our earlier work that demonstrated that the UHB-flanked ospE gene family undergoes mutation and recombination during infection (20), we hypothesized that similar molecular events occur in the ospF gene family during infection. One possible consequence of these processes could be the generation of antigenic variants that contribute to immune evasion. To test this hypothesis, we analyzed the genetic stability and humoral immune response to individual members of the OspF protein family using the murine model for Lyme disease. Analyses of ospF genetic stability focused on a series of B. burgdorferi clones recovered from C3H-HeJ mice that had been infected for 12 weeks with B. burgdorferi B31MI (20). The clonal populations analyzed in this report were the same populations previously found to undergo mutation in their ospE genes. In this report, we also demonstrate that mutations develop within the vlsE gene of these clones during infection. However, in contrast to ospE and vlsE, SNP analyses of BBO39, BBR42, and BBM38 revealed that the frequency of mutation in these genes during infection is low. As an additional means for testing for the development of mutations, complete sequence analysis of several of the ospF gene family member PCR amplicons was performed. As with the SNP analyses, mutations were not detected. In an earlier analysis, we demonstrated that BBS41 (a peripheral member of the ospF family) is also stable during infection (20). The absence of mutation in the ospF gene family members and the peripherally related BBS41 gene, in a background that is known to undergo mutation during infection, indicates that ospF gene family members are stable during infection in mice.
Prior to this report, little was known about the patterns of expression of the OspF protein family during infection. As a means of assessing the expression patterns and to characterize the specificity of the humoral response, each of the ospF family members from B. burgdorferi B31MI was cloned and expressed in E. coli for use in immunoblot analyses. After confirming that the constructs were expressed at similar levels in E. coli, the r-proteins were screened with a polyclonal anti-OspF antiserum generated using r-protein of B. burgdorferi N40 origin (9). This antiserum recognized r-forms of BBO39 and BBR42 but not BBM38, indicating that BBM38 is antigenically distinct from other OspF family member proteins.
To assess the expression patterns and the specificity of the immune response to the OspF proteins during infection, immunoblots of these proteins were screened with infection sera from several mice that were collected over the course of infection. Sera collected after 6 weeks of infection from mice infected with B. burgdorferi B31MI pc were found to possess antibodies to BBO39 but not to BBR42 or BBM38. This observation demonstrates that anti-BBO39 antibodies are not immunologically cross-reactive with BBM38 or BBR42. A significant response to BBM38 and BBR42 did not develop in any of the B31MI pc-infected mice analyzed, even after 12 weeks of infection. A similar trend was also observed in the mice infected with B. burgdorferi B31MI c53. While a strong IgG response did develop by week 12 in c53-infected mice, it is clear from both experiments that a significant IgG response to BBR42 and BBM38 develops considerably later than to BBO39. As all OspF-related proteins that have been analyzed to date have been demonstrated to be immunogenic in mice (17), it is possible that the delayed response to BBR42 and BBM38 results from the temporal expression of these proteins during infection. One possible explanation for the detection of antibodies to BBR42 and BBM38 in the B31MI c53-infected mice was that there is some degree of cross-reactivity of the anti-BBO39 antibodies with these proteins. However, preabsorption of these infection sera with lysates of E. coli that had been induced to express BBO39 confirmed that the IgG response to these proteins was specific and not due to cross-reactivity.
To determine if infection with other isolates results in the late-stage production of antibodies that recognize BBO39, BBR42, or BBM38, mice were infected with the B. burgdorferi isolates N40 and 297. During the early stages of infection, these mice produced antibodies that recognize r-BBO39 but not BBR42 or BBM38. The absence of antibodies to BBR42 and BBM38 in sera collected during early infection suggests either that these proteins are not expressed or that 297 and N40 encode variants of these proteins that are antigenically distinct from that carried by B31MI. Immunoblot analyses of late-stage infection sera revealed that mice infected with N40 but not 297 develop anti-BBR42 antibodies. As in the mice infected with B31MI clones pc and c53, the antibody response to these proteins suggests temporal expression of BBR42. Antibodies to BBM38 were not detected in any of the serum samples from the N40- or 297-infected mice. As described above, we were able to amplify BBO39 and BBR42 from both 297 and N40 but could only amplify BBM38 from isolate 297. The absence of antibodies to BBM38 and BBR42 in the 297 infection sera may indicate that these proteins are not expressed by this isolate during infection or that they are expressed at a time point later than 12 weeks. Since BBM38 could not be amplified from isolate N40, no conclusion can be reached at this time about the lack of anti-BBM38 antibodies in the N40 infection-derived sera.
The apparent temporal expression of BBR42 and BBM38 during infection is consistent with and may explain some earlier data reported by Nguyen et al (13). It was demonstrated that antibodies to an OspF-related protein of N40 could be detected in only 14% of Lyme disease patients with "early Lyme disease." In contrast, an antibody response to OspF was detected in 58% of the patients with late Lyme disease. It was also demonstrated that antibodies to B. burgdorferi N40 OspF did not develop in mice infected with N40 until 90 days into the infection. The time frame of development of the humoral immune response to OspF-related proteins in this earlier report is consistent with that reported here for BBR42 and BBM38. At the time that Nguyen et al. conducted their analyses, a completed genome sequence for B. burgdorferi was not available, and it had not yet been demonstrated that OspF belongs to a paralogous protein family. As a result, it was not possible for those authors to specifically determine which ospF allele(s) was or was not being expressed. By exploiting the genome sequence, we have been able to demonstrate which specific members of the OspF family are expressed at which relative stages of infection.
In an earlier analysis, Stevenson et al. reported that an IgG response to the OspF family members BBO39 and BBM38 could be detected in a mouse infected with B. burgdorferi for 4 weeks (17). Consistent with this, we also detected an IgG response to BBO39 during early infection. However, in contrast, we did not detect an early IgG response to BBM38. The observed immunoreactivity of r-BBM38 (referred to as ErpK in the aforementioned study) noted by Stevenson et al. was relatively weak, and the size of the immunoreactive protein was not consistent with that predicted for BBM38. A second important point is that upon analysis of serum samples from human Lyme disease patients, Stevenson et al. reported that only 2 of the 10 patient sera analyzed had anti-BBM38 antibodies. This observation may be inconsistent with the authors' conclusion that all OspE- and OspF-related proteins are expressed early during infection. It is possible that the absence of a detectable response to BBM38 in these human serum samples could reflect the time point at which the sera were collected. The data presented here would suggest that if the sera were collected during early infection, an IgG response to BBM38 might not be observed due to the expression of this gene during later stages of infection. Unfortunately, the time point during infection at which the human sera were collected was not known to the authors, and hence it is not possible to further assess these earlier data. The basis for the discrepancies regarding the expression patterns of the OspF proteins reported here and by Nguyen et al. (13) with that reported by Stevenson and colleagues is unclear. Note that BBR42 expression was not specifically analyzed by Stevenson et al., and hence we cannot compare and contrast data regarding the expression of this specific protein.
In an attempt to identify the potential molecular basis for the
differential expression of BBO39, BBR42, and BBM38, the UHB elements
for these genes, which harbor the promoter elements, were aligned and
compared (Fig. 6). A 192-nucleotide
stretch located upstream from the translational start codon of BBM38
and BBR42 exhibits 93.7 and 80% identity, respectively, with that of
BBO39. In addition, although the precise locations of the
35 and
10 elements have not been experimentally defined, a putative consensus
10 is evident in all. A 30-nucleotide stretch immediately upstream of
the
10 exhibits only minor sequence variation. Nonetheless, it is
possible that these minor sequence changes could influence the
transcription of these genes. It is also possible that all of the OspF
genes, including BBM38 and BBR42, are transcribed during early
infection but that protein production is posttranscriptionally regulated. Recent findings by Hefty et al. suggest that some
UHB-flanked genes of B. burgdorferi 297 are transcribed in
the mammal but that protein production is posttranscriptionally
repressed (8). The precise mechanism(s) by which temporal
transcription or protein production occurs will require further
experimentation and analysis. In closing, the data presented here
further illustrate the dynamics of protein expression in Lyme disease
spirochetes. The study of the temporal component of protein expression
will provide significant insight into the nature of the host-pathogen
relationship over the course of disease.
|
| |
ACKNOWLEDGMENTS |
|---|
We thank Darrin Akins and Scott Hefty for helpful discussions and for sharing data prior to publication. In addition, we thank the Molecular Pathogenesis Group at Virginia Commonwealth University for insightful comments and advice.
This work was supported in parts by grants from Virginia's Commonwealth Health Research Board, the Jeffress Trust, and the National Institutes of Health.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA 23298-0678, Phone: (804) 828-3779. Fax: (804) 828-9946. E-mail: rmarconi{at}hsc.vcu.edu.
Editor: V. J. DiRita
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Akins, D., S. F. Porcella, T. G. Popova, D. Shevchenko, S. I. Baker, M. Li, M. V. Norgard, and J. D. Radolf. 1995. Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue. Mol. Microbiol. 18:507-520[CrossRef][Medline]. |
| 2. |
Akins, D. R.,
M. J. Caimano,
X. Yang,
F. Cerna,
M. V. Norgard, and J. D. Radolf.
1999.
Molecular and evolutionary analysis of Borrelia burgdorferi 297 circular plasmid-encoded lipoproteins with OspE- and OspF-like leader peptides.
Infect. Immun.
67:1526-1532 |
| 3. | Barbour, A. G. 1990. Antigenic variation of a relapsing fever Borrelia species. Annu. Rev. Microbiol. 44:155-171[CrossRef][Medline]. |
| 4. | Casjens, S., N. Palmer, R. van Vugt, W. M. Huang, B. Stevenson, P. Rosa, R. Lathigra, G. Sutton, J. Peterson, R. J. Dodson, D. Haft, E. Hickey, M. Gwinn, O. White, and C. M. Fraser. 2000. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 35:490-516[CrossRef][Medline]. |
| 5. |
Casjens, S.,
R. van Vugt,
K. Tilly,
P. A. Rosa, and B. Stevenson.
1997.
Homology throughout the multiple 32 kilobase circular plasmids in Lyme disease spirochetes.
J. Bacteriol.
179:217-227 |
| 6. | Das, S., S. W. Barthold, S. S. Giles, R. R. Montgomery, S. R. Telford III, and E. Fikrig. 1997. Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host. J. Clin. Investig. 99:987-995[Medline]. |
| 7. | Fraser, C., S. Casjens, W. M. Huang, G. G. Sutton, R. Clayton, R. Lathigra, O. White, K. A. Ketchum, R. Dodson, E. K. Hickey, M. Gwinn, B. Dougherty, J. F. Tomb, R. D. Fleischman, D. Richardson, J. Peterson, A. R. Kerlavage, J. Quackenbush, S. Salzberg, M. Hanson, R. Vugt, N. Palmer, M. D. Adams, J. Gocayne, J. Weidman, T. Utterback, L. Watthey, L. McDonald, P. Artiach, C. Bowman, S. Garland, C. Fujii, M. D. Cotton, K. Horst, K. Roberts, B. Hatch, H. O. Smith, and J. C. Venter. 1997. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580-586[CrossRef][Medline]. |
| 8. |
Hefty, P. S.,
S. E. Jolliff,
M. J. Caimano,
S. K. Wikel,
J. D. Radolf, and J. R. Akins.
2001.
Regulation of the OspE-related, OspF-related, and Elp lipoproteins of Borrelia burgdorferi strain 297 by mammalian host-specific signals.
Infect. Immun.,
69:3618-3627 |
| 9. |
Lam, T. T.,
T.-P. K. Nguyen,
R. R. Montgomery,
F. S. Kantor,
E. Fikrig, and R. A. Flavell.
1994.
Outer surface protein E and F of Borrelia burgdorferi, the agent of Lyme disease.
Infect. Immun.
62:290-298 |
| 10. |
Marconi, R. T.,
D. S. Samuels, and C. F. Garon.
1993.
Transcriptional analyses and mapping of the ospC gene in Lyme disease spirochetes.
J. Bacteriol.
175:926-932 |
| 11. |
Marconi, R. T.,
S. Y. Sung,
C. N. Hughes, and J. A. Carlyon.
1996.
Molecular and evolutionary analyses of a variable series of genes in Borrelia burgdorferi that are related to ospE and ospF, constitute a gene family, and share a common upstream homology box.
J. Bacteriol.
178:5615-5626 |
| 12. |
McDowell, J. V.,
J. T. Skare,
S.-Y. Sung, and R. T. Marconi.
2001.
Analysis of mechanisms associated with the loss of infectivity of clonal populations of Borrelia burgdorferi B31MI.
Infect. Immun.,
69:3670-3677 |
| 13. |
Nguyen, T.-P. K.,
T. T. Lam,
S. W. Barthold,
S. R. Telford III,
R. A. Flavell, and E. Fikrig.
1994.
Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE- or OspF-immunized mice.
Infect. Immun.
62:2079-2084 |
| 14. |
Purser, J. E., and S. J. Norris.
2000.
Correlation between plasmid content and infectivity in Borrelia burgdorferi.
Proc. Natl. Acad. Sci. USA
97:13865-13870 |
| 15. | Roberts, D. M., J. A. Carlyon, M. Theisen, and R. T. Marconi. 2000. The bdr gene families of the Lyme disease and relapsing fever spirochetes: possible influence on biology, pathogenesis and evolution. Emerg. Infect. Dis. 6:110-122[Medline]. |
| 16. |
Schwan, T. G.,
W. Burgdorfer, and C. F. Garon.
1988.
Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation.
Infect. Immun.
56:1831-1836 |
| 17. |
Stevenson, B.,
J. L. Bono,
T. G. Schwan, and P. Rosa.
1998.
Borrelia burgdorferi Erp proteins are immunogenic in mammals infected by tick bite, and their synthesis is inducible in cultured bacteria.
Infect. Immun.
66:2648-2654 |
| 18. |
Stevenson, B.,
S. Casjens, and P. Rosa.
1998.
Evidence of past recombination events among the genes encoding Erp antigens of Borrelia burgdorferi.
Microbiology
144:1869-1879 |
| 19. |
Stevenson, B.,
K. Tilly, and P. A. Rosa.
1996.
A family of genes located on four separate 32 kilobase circular plasmids in Borrelia burgdorferi B31.
J. Bacteriol.
178:3508-3516 |
| 20. |
Sung, S. Y.,
J. McDowell,
J. A. Carlyon, and R. T. Marconi.
2000.
Mutation and recombination in the upstream homology box flanked ospE related genes of the Lyme disease spirochetes results in the development of new antigenic variants during infection.
Infect. Immun.
68:1319-1327 |
| 21. |
Sung, S.-Y.,
C. LaVoie,
J. A. Carlyon, and R. T. Marconi.
1998.
Genetic divergence and evolutionary instability in ospE-related members of the upstream homology box gene family in Borrelia burgdorferi sensu lato complex isolates.
Infect. Immun.
66:4656-4668 |
| 22. | Wallich, R., C. Brenner, M. D. Kramer, and M. M. Simon. 1995. Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo. Infect. Immun. 63:3327-3335[Abstract]. |
| 23. | Zhang, J.-R., J. M. Hardham, A. G. Barbour, and A. G. Norris. 1997. Antigenic variation in Lyme disease borreliae by promiscuous recombination of vmp like sequence cassettes. Cell 89:275-285[CrossRef][Medline]. |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»